Myeloid/natural killer cell precursor and myeloid/natural killer cell acute leukemia / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 525-529, 2014.
Article
Dans Chinois
| WPRIM
| ID: wpr-349677
ABSTRACT
With the popularity of flow cytometry, the classification of leukemia become more detailed. Myeloid/natural killer cell precursor acute leukemia and myeloid/natural killer cell acute leukemias are generally recognized as two kinds of rare leukemias and have poor prognosis. The cells expressed both myeloid and lymphatic antigens in these two leukemia and can not be diagnosed by morphology. The only basis to make a definite diagnosis is their unique Immunophenotyping. The role of CD7 and CD56 in these two leukemia are compelling, in the other hand, as the progress of cell differentiation research, there are many new awareness of NK cell differentiation. In this article, the biological origin, clinical manifestation, diagnosis, treatment and the role of CD7 and CD56 in these two leukemia are briefly summarized.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Thérapeutique
/
Cellules tueuses naturelles
/
Leucémie aigüe myéloïde
/
Différenciation cellulaire
/
Classification
/
Antigènes CD7
/
Antigènes CD56
/
Diagnostic
Type d'étude:
Etude diagnostique
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Journal of Experimental Hematology
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS